{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T15:28:31Z","timestamp":1792337311772,"version":"4.4.0"},"reference-count":100,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T00:00:00Z","timestamp":1611878400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R15CA176496"],"award-info":[{"award-number":["R15CA176496"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>Extracellular signal-regulated kinase (ERK5) is an essential regulator of cancer progression, tumor relapse, and poor patient survival. Epithelial to mesenchymal transition (EMT) is a complex oncogenic process, which drives cell invasion, stemness, and metastases. Activators of ERK5, including mitogen-activated protein kinase 5 (MEK5), tumor necrosis factor \u03b1 (TNF-\u03b1), and transforming growth factor-\u03b2 (TGF-\u03b2), are known to induce EMT and metastases in breast, lung, colorectal, and other cancers. Several downstream targets of the ERK5 pathway, such as myocyte-specific enhancer factor 2c (MEF2C), activator protein-1 (AP-1), focal adhesion kinase (FAK), and c-Myc, play a critical role in the regulation of EMT transcription factors SNAIL, SLUG, and \u03b2-catenin. Moreover, ERK5 activation increases the release of extracellular matrix metalloproteinases (MMPs), facilitating breakdown of the extracellular matrix (ECM) and local tumor invasion. Targeting the ERK5 signaling pathway using small molecule inhibitors, microRNAs, and knockdown approaches decreases EMT, cell invasion, and metastases via several mechanisms. The focus of the current review is to highlight the mechanisms which are known to mediate cancer EMT via ERK5 signaling. Several therapeutic approaches that can be undertaken to target the ERK5 pathway and inhibit or reverse EMT and metastases are discussed.<\/jats:p>","DOI":"10.3390\/biom11020183","type":"journal-article","created":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T02:58:21Z","timestamp":1611889101000},"page":"183","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Molecular Mechanisms of Epithelial to Mesenchymal Transition Regulated by ERK5 Signaling"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4548-7727","authenticated-orcid":false,"given":"Akshita B.","family":"Bhatt","sequence":"first","affiliation":[{"name":"Department of Pharmacology, School of Pharmacy, Duquesne University, Pittsburgh, PA 15282, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saloni","family":"Patel","sequence":"additional","affiliation":[{"name":"Department of Medicinal Chemistry, School of Pharmacy, Duquesne University, Pittsburgh, PA 15282, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarite D.","family":"Matossian","sequence":"additional","affiliation":[{"name":"Department of Medicine, Tulane University School of Medicine, New Orleans, LA 70112, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deniz A.","family":"Ucar","sequence":"additional","affiliation":[{"name":"Department of Genetics and Stanley S. Scott Cancer Center, Louisiana State University Health Sciences Center, New Orleans, LA 70112, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucio","family":"Miele","sequence":"additional","affiliation":[{"name":"Department of Genetics and Stanley S. Scott Cancer Center, Louisiana State University Health Sciences Center, New Orleans, LA 70112, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew E.","family":"Burow","sequence":"additional","affiliation":[{"name":"Department of Medicine, Tulane University School of Medicine, New Orleans, LA 70112, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick T.","family":"Flaherty","sequence":"additional","affiliation":[{"name":"Department of Medicinal Chemistry, School of Pharmacy, Duquesne University, Pittsburgh, PA 15282, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane E.","family":"Cavanaugh","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, School of Pharmacy, Duquesne University, Pittsburgh, PA 15282, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,1,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Roche, J. (2018). The Epithelial-to-Mesenchymal Transition in Cancer. Cancers, 10.","DOI":"10.3390\/cancers10020052"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrm1835","article-title":"Complex networks orchestrate epithelial\u2013mesenchymal transitions","volume":"7","author":"Thiery","year":"2006","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Sinha, D., Saha, P., Samanta, A., and Bishayee, A. (2020). Emerging Concepts of Hybrid Epithelial-to-Mesenchymal Transition in Cancer Progression. Biomolecules, 10.","DOI":"10.3390\/biom10111561"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"447","DOI":"10.4161\/cam.4.3.10771","article-title":"Transitions between epithelial and mesenchymal states and the morphogenesis of the early mouse embryo","volume":"4","author":"Viotti","year":"2010","journal-title":"Cell Adhes. Migr."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/s41586-019-1897-5","article-title":"TGF-\u03b2 orchestrates fibrogenic and developmental EMTs via the RAS effector RREB1","volume":"577","author":"Su","year":"2020","journal-title":"Nature"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1038\/ncb2607","article-title":"Elf5 inhibits the epithelial-mesenchymal transition in mammary gland development and breast cancer metastasis by transcriptionally repressing Snail2","volume":"14","author":"Chakrabarti","year":"2012","journal-title":"Nat. Cell Biol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1083\/jcb.200109037","article-title":"Ras and TGF[beta] cooperatively regulate epithelial cell plasticity and metastasis: Dissection of Ras signaling pathways","volume":"156","author":"Janda","year":"2002","journal-title":"J. Cell Biol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nrc.2017.118","article-title":"EMT in cancer","volume":"18","author":"Brabletz","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1242\/jcs.100115","article-title":"E-cadherin-integrin crosstalk in cancer invasion and metastasis","volume":"126","author":"Canel","year":"2013","journal-title":"J. Cell Sci."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1002\/1878-0261.12095","article-title":"EMT and inflammation: Inseparable actors of cancer progression","volume":"11","author":"Lesage","year":"2017","journal-title":"Mol. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e1002731","DOI":"10.1080\/2162402X.2014.1002731","article-title":"The mutually regulatory loop of epithelial\u2013mesenchymal transition and immunosuppression in cancer progression","volume":"4","author":"Chen","year":"2015","journal-title":"OncoImmunology"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"5241","DOI":"10.1038\/ncomms6241","article-title":"Metastasis is regulated via microRNA-200\/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression","volume":"5","author":"Chen","year":"2014","journal-title":"Nat. Commun."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Genna, A., Vanwynsberghe, A.M., Villard, A.V., Pottier, C., Ancel, J., Polette, M., and Gilles, C. (2020). EMT-Associated Heterogeneity in Circulating Tumor Cells: Sticky Friends on the Road to Metastasis. Cancers, 12.","DOI":"10.3390\/cancers12061632"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/nrclinonc.2017.44","article-title":"EMT, CSCs, and drug resistance: The mechanistic link and clinical implications","volume":"14","author":"Shibue","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1101\/gad.1950610","article-title":"Repression of the miR-143\/145 cluster by oncogenic Ras initiates a tumor-promoting feed-forward pathway","volume":"24","author":"Kent","year":"2010","journal-title":"Genes Dev."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-018-07130-z","article-title":"Genetic dissection of the miR-200\u2013Zeb1 axis reveals its importance in tumor differentiation and invasion","volume":"9","author":"Title","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.canlet.2017.01.034","article-title":"Oncogenic signaling of MEK5-ERK5","volume":"392","author":"Hoang","year":"2017","journal-title":"Cancer Lett."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"20993","DOI":"10.1074\/jbc.M604208200","article-title":"Global gene expression analysis of ERK5 and ERK1\/2 signaling reveals a role for HIF-1 in ERK5-mediated responses","volume":"281","author":"Schweppe","year":"2006","journal-title":"J. Biol. Chem."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1016\/j.cellsig.2012.07.007","article-title":"ERK5: Structure, regulation and function","volume":"24","author":"Wilm","year":"2012","journal-title":"Cell. Signal."},{"key":"ref_20","first-page":"91","article-title":"DCLK1 is correlated with MET and ERK5 expression, and associated with prognosis in malignant pleural mesothelioma","volume":"51","author":"Wang","year":"2017","journal-title":"Int. J. Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1038\/sj.onc.1206154","article-title":"MEK5 overexpression is associated with metastatic prostate cancer, and stimulates proliferation, MMP-9 expression and invasion","volume":"22","author":"Mehta","year":"2003","journal-title":"Oncogene"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1210\/me.2016-1101","article-title":"ER\u03b1-XPO1 Cross Talk Controls Tamoxifen Sensitivity in Tumors by Altering ERK5 Cellular Localization","volume":"30","author":"Wrobel","year":"2016","journal-title":"Mol. Endocrinol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"99","DOI":"10.18632\/oncoscience.135","article-title":"MEK5-ERK5 pathway associates with poor survival of breast cancer patients after systemic treatments","volume":"2","author":"Miranda","year":"2015","journal-title":"Oncoscience"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e2415","DOI":"10.1038\/cddis.2016.333","article-title":"CDK5 functions as a tumor promoter in human colorectal cancer via modulating the ERK5\u2013AP-1 axis","volume":"7","author":"Zhuang","year":"2016","journal-title":"Cell Death Dis."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1002\/mc.22420","article-title":"MAPK7gene controls proliferation, migration and cell invasion in osteosarcoma","volume":"55","author":"Lopes","year":"2016","journal-title":"Mol. Carcinog."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.abb.2017.07.011","article-title":"MiR-143 regulates the proliferation and migration of osteosarcoma cells through targeting MAPK7","volume":"630","author":"Dong","year":"2017","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"74435","DOI":"10.18632\/oncotarget.12908","article-title":"Absence of ERK5\/MAPK7 delays tumorigenesis in Atm-\/- mice","volume":"7","author":"Gamez","year":"2016","journal-title":"Oncotarget"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nrc3760","article-title":"Targeting RAF kinases for cancer therapy: BRAF-mutated melanoma and beyond","volume":"14","author":"Holderfield","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1177\/1947601910373795","article-title":"The Role of B-RAF Mutations in Melanoma and the Induction of EMT via Dysregulation of the NF-\u03baB\/Snail\/RKIP\/PTEN Circuit","volume":"1","author":"Lin","year":"2010","journal-title":"Genes Cancer"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1002\/jcb.29350","article-title":"Pharmacological inhibition of the MEK5\/ERK5 and PI3K\/Akt signaling pathways synergistically reduces viability in triple-negative breast cancer","volume":"121","author":"Wright","year":"2020","journal-title":"J. Cell. Biochem."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1165\/rcmb.2007-0206OC","article-title":"HGF Mediates Cell Proliferation of Human Mesothelioma Cells through a PI3K\/MEK5\/Fra-1 Pathway","volume":"38","author":"Blumen","year":"2008","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"ra102","DOI":"10.1126\/scisignal.2005470","article-title":"The kinase ALK stimulates the kinase ERK5 to promote the expression of the oncogene MYCN in neuroblastoma","volume":"7","author":"Umapathy","year":"2014","journal-title":"Sci. Signal."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"R60","DOI":"10.1186\/bcr2622","article-title":"Breast tumor kinase and extracellular signal-regulated kinase 5 mediate Met receptor signaling to cell migration in breast cancer cells","volume":"12","author":"Castro","year":"2010","journal-title":"Breast Cancer Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.cellsig.2016.06.013","article-title":"Platelet-derived growth factor (PDGF)-induced activation of Erk5 MAP-kinase is dependent on Mekk2, Mek1\/2, PKC and PI3-kinase, and affects BMP signaling","volume":"28","author":"Tsioumpekou","year":"2016","journal-title":"Cell. Signal."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"4492","DOI":"10.1182\/blood-2004-08-2985","article-title":"Multifunctional role of Erk5 in multiple myeloma","volume":"105","author":"Tabera","year":"2005","journal-title":"Blood"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"672","DOI":"10.3389\/fonc.2019.00672","article-title":"Novel Diphenylamine Analogs Induce Mesenchymal to Epithelial Transition in Triple Negative Breast Cancer","volume":"9","author":"Bhatt","year":"2019","journal-title":"Front. Oncol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"11551","DOI":"10.1038\/ncomms11551","article-title":"ERK5 signalling rescues intestinal epithelial turnover and tumour cell proliferation upon ERK1\/2 abrogation","volume":"7","author":"Taniguchi","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.ccell.2018.10.001","article-title":"KRAS Suppression-Induced Degradation of MYC is Antagonized by a MEK5-ERK5 Compensatory Mechanism","volume":"34","author":"Vaseva","year":"2018","journal-title":"Cancer Cell"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"46244","DOI":"10.1038\/srep46244","article-title":"Targeting BMK1 Impairs the Drug Resistance to Combined Inhibition of BRAF and MEK1\/2 in Melanoma","volume":"7","author":"Song","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1158\/0008-5472.CAN-18-2762","article-title":"Resistance to MAPK Inhibitors in Melanoma Involves Activation of the IGF1R\u2013MEK5\u2013Erk5 Pathway","volume":"79","year":"2019","journal-title":"Cancer Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.yexcr.2014.10.003","article-title":"The MAPK ERK5, but not ERK1\/2, inhibits the progression of monocytic phenotype to the functioning macrophage","volume":"330","author":"Wang","year":"2015","journal-title":"Exp. Cell Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1016\/j.jid.2020.03.972","article-title":"Efficient Suppression of NRAS-Driven Melanoma by Co-inhibition of ERK1\/2 and ERK5 MAPK Pathways","volume":"140","author":"Adam","year":"2020","journal-title":"J. Investig. Dermatol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1038\/s41388-018-0164-9","article-title":"ERK5 is activated by oncogenic BRAF and promotes melanoma growth","volume":"37","author":"Tusa","year":"2018","journal-title":"Oncogene"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Honda, T., Obara, Y., Yamauchi, A., Couvillon, A.D., Mason, J.J., Ishii, K., and Nakahata, N. (2015). Phosphorylation of ERK5 on Thr732 Is Associated with ERK5 Nuclear Localization and ERK5-Dependent Transcription. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0117914"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1002\/mc.22445","article-title":"miR-143 suppresses epithelial-mesenchymal transition and inhibits tumor growth of breast cancer through down-regulation of ERK5","volume":"55","author":"Zhai","year":"2016","journal-title":"Mol. Carcinog."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.bbrc.2016.08.085","article-title":"MicroRNA-200b-3p suppresses epithelial-mesenchymal transition and inhibits tumor growth of glioma through down-regulation of ERK5","volume":"478","author":"Wu","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/bjc.2012.34","article-title":"A cohort study of the prognostic and treatment predictive value of SATB2 expression in colorectal cancer","volume":"106","author":"Eberhard","year":"2012","journal-title":"Br. J. Cancer"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/path.2575","article-title":"Down-regulated expression of SATB2 is associated with metastasis and poor prognosis in colorectal cancer","volume":"219","author":"Wang","year":"2009","journal-title":"J. Pathol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"e12455","DOI":"10.1111\/cpr.12455","article-title":"SATB2 targeted by methylated miR-34c-5p suppresses proliferation and metastasis attenuating the epithelial-mesenchymal transition in colorectal cancer","volume":"51","author":"Gu","year":"2018","journal-title":"Cell Prolif."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1111\/febs.13227","article-title":"SATB2 suppresses the progression of colorectal cancer cells via inactivation of MEK5\/ERK5 signaling","volume":"282","author":"Mansour","year":"2015","journal-title":"FEBS J."},{"key":"ref_51","first-page":"649-IN17","article-title":"ERK5\/BMK1 Is a Novel Target of the Tumor Suppressor VHL: Implication in Clear Cell Renal Carcinoma","volume":"15","author":"Leticia","year":"2013","journal-title":"Neoplasia"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s11912-009-0015-5","article-title":"VHL gene mutations in renal cell carcinoma: Role as a biomarker of disease outcome and drug efficacy","volume":"11","author":"Cowey","year":"2009","journal-title":"Curr. Oncol. Rep."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Antoon, J.W., Martin, E.C., Lai, R., Salvo, V.A., Tang, Y., Nitzchke, A.M., Elliott, S., Nam, S.Y., Xiong, W., and Rhodes, L.V. (2013). MEK5\/ERK5 Signaling Suppresses Estrogen Receptor Expression and Promotes Hormone-Independent Tumorigenesis. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0069291"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"R105","DOI":"10.1186\/bcr2210","article-title":"Proteomic analysis of tumor necrosis factor-\u03b1 resistant human breast cancer cells reveals a MEK5\/Erk5-mediated epithelial-mesenchymal transition phenotype","volume":"10","author":"Zhou","year":"2008","journal-title":"Breast Cancer Res."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Dompe, N., Klijn, C., Watson, S.A., Leng, K., Port, J., Cuellar, T., Watanabe, C., Haley, B., Neve, R., and Evangelista, M. (2018). A CRISPR screen identifies MAPK7 as a target for combination with MEK inhibition in KRAS mutant NSCLC. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0199264"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"8301","DOI":"10.1038\/sj.onc.1208026","article-title":"Stat3 upregulates MEK5 expression in human breast cancer cells","volume":"23","author":"Song","year":"2004","journal-title":"Oncogene"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3892\/or.2016.5256","article-title":"Upregulation of MEK5 by Stat3 promotes breast cancer cell invasion and metastasis","volume":"37","author":"Liu","year":"2017","journal-title":"Oncol. Rep."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1158\/1541-7786.MCR-14-0604","article-title":"MAPK7 Regulates EMT Features and Modulates the Generation of CTCs","volume":"13","author":"Javaid","year":"2015","journal-title":"Mol. Cancer Res."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1074\/jbc.274.1.143","article-title":"Fluid shear stress stimulates big mitogen-activated protein kinase 1 (BMK1) activity in endothelial cells. Dependence on tyrosine kinases and intracellular calcium","volume":"274","author":"Yan","year":"1999","journal-title":"J. Biol. Chem."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Moncho-Amor, V., Pintado-Berninches, L., De Caceres, I.I., Mart\u00edn-Villar, E., Quintanilla, M., Chakravarty, P., Cortes-Sempere, M., Fern\u00e1ndez-Varas, B., Rodriguez-Antol\u00edn, C., and De Castro, J. (2019). Role of Dusp6 Phosphatase as a Tumor Suppressor in Non-Small Cell Lung Cancer. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20082036"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1158\/1541-7786.MCR-13-0588","article-title":"Novel Roles for ERK5 and Cofilin as Critical Mediators Linking ER\u03b1-Driven Transcription, Actin Reorganization, and Invasiveness in Breast Cancer","volume":"12","author":"Ventrella","year":"2014","journal-title":"Mol. Cancer Res."},{"key":"ref_62","first-page":"169","article-title":"How cells read TGF-beta signals. Nature reviews","volume":"1","year":"2000","journal-title":"Mol. Cell Biol."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Hao, Y., Baker, D., and Dijke, P.T. (2019). TGF-\u03b2-Mediated Epithelial-Mesenchymal Transition and Cancer Metastasis. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20112767"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"4197","DOI":"10.1038\/s41388-018-0270-8","article-title":"A kinome-wide high-content siRNA screen identifies MEK5\u2013ERK5 signaling as critical for breast cancer cell EMT and metastasis","volume":"37","author":"Pavan","year":"2018","journal-title":"Oncogene"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.bbrc.2008.06.058","article-title":"TGF-beta activates ERK5 in human renal epithelial cells","volume":"373","author":"Browne","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s13238-020-00701-1","article-title":"Extracellular signal regulated kinase 5 promotes cell migration, invasion and lung metastasis in a FAK-dependent manner","volume":"11","author":"Jiang","year":"2020","journal-title":"Protein Cell"},{"key":"ref_67","first-page":"496","article-title":"Regulating Rho GTPases and their regulators. Nature reviews","volume":"17","author":"Hodge","year":"2016","journal-title":"Mol. Cell Biol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1016\/j.yexcr.2008.09.013","article-title":"TGF-\u03b2 induces formation of F-actin cores and matrix degradation in human breast cancer cells via distinct signaling pathways","volume":"314","author":"Mandal","year":"2008","journal-title":"Exp. Cell Res."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1083\/jcb.200801078","article-title":"ERK5 promotes Src-induced podosome formation by limiting Rho activation","volume":"181","author":"Schramp","year":"2008","journal-title":"J. Cell Biol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1242\/jcs.02308","article-title":"Activation of either ERK1\/2 or ERK5 MAP kinase pathways can lead to disruption of the actin cytoskeleton","volume":"118","author":"Barros","year":"2005","journal-title":"J. Cell Sci."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/sj.bjc.6606062","article-title":"ERK5 signalling in prostate cancer promotes an invasive phenotype","volume":"104","author":"Ramsay","year":"2011","journal-title":"Br. J. Cancer"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.3389\/fonc.2020.01164","article-title":"ERK5 Is Required for Tumor Growth and Maintenance Through Regulation of the Extracellular Matrix in Triple Negative Breast Cancer","volume":"10","author":"Hoang","year":"2020","journal-title":"Front. Oncol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1535-6108(03)00162-4","article-title":"ERK-MAPK signaling coordinately regulates activity of Rac1 and RhoA for tumor cell motility","volume":"4","author":"Vial","year":"2003","journal-title":"Cancer Cell"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1038\/sj.onc.1208312","article-title":"FRA-1 expression level regulates proliferation and invasiveness of breast cancer cells","volume":"24","author":"Belguise","year":"2005","journal-title":"Oncogene"},{"key":"ref_75","first-page":"37","article-title":"MEK5\/ERK5 pathway: The first fifteen years","volume":"1825","author":"Drew","year":"2012","journal-title":"Biochim. Biophys. Acta (BBA) Bioenerg."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3389\/fcell.2019.00135","article-title":"Mechanochemical Signaling of the Extracellular Matrix in Epithelial-Mesenchymal Transition","volume":"7","author":"Scott","year":"2019","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/jcp.21662","article-title":"A novel role of ERK5 in integrin-mediated cell adhesion and motility in cancer cells via Fak signaling","volume":"219","author":"Sawhney","year":"2009","journal-title":"J. Cell. Physiol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.bbrc.2019.03.145","article-title":"CRISPR\/Cas9 engineering of ERK5 identifies its FAK\/PYK2 dependent role in adhesion-mediated cell survival","volume":"513","author":"Ali","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1155\/2011\/870459","article-title":"Tyrosine phosphatases in the HER2-directed motility of ovarian cancer cells: Involvement of PTPN12, ERK5 and FAK","volume":"34","year":"2011","journal-title":"Anal. Cell. Pathol."},{"key":"ref_80","first-page":"2640","article-title":"ERK5 silencing inhibits invasion of human osteosarcoma cell via modulating the Slug\/MMP-9 pathway","volume":"18","author":"Yue","year":"2014","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"e1718","DOI":"10.1038\/cddis.2015.83","article-title":"Aberrant MEK5\/ERK5 signalling contributes to human colon cancer progression via NF-\u03baB activation","volume":"6","author":"Pereira","year":"2015","journal-title":"Cell Death Dis."},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Pereira, D.M., Gomes, S.E., Borralho, P.M., and Rodrigues, C.M.P. (2019). MEK5\/ERK5 activation regulates colon cancer stem-like cell properties. Cell Death Discov., 5.","DOI":"10.1038\/s41420-019-0150-1"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1158\/1541-7786.MCR-15-0450","article-title":"Kinase-Dependent and -Independent Roles for PTK6 in Colon Cancer","volume":"14","author":"Mathur","year":"2016","journal-title":"Mol. Cancer Res."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.canlet.2014.05.011","article-title":"XMD8-92 inhibits pancreatic tumor xenograft growth via a DCLK1-dependent mechanism","volume":"351","author":"Sureban","year":"2014","journal-title":"Cancer Lett."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.stemcr.2018.08.016","article-title":"Targeting the Extracellular Signal-Regulated Kinase 5 Pathway to Suppress Human Chronic Myeloid Leukemia Stem Cells","volume":"11","author":"Tusa","year":"2018","journal-title":"Stem Cell Rep."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"E2801","DOI":"10.1073\/pnas.1707929115","article-title":"Myeloid ERK5 deficiency suppresses tumor growth by blocking protumor macrophage polarization via STAT3 inhibition","volume":"115","author":"Giurisato","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1158\/0008-5472.CAN-13-3043","article-title":"ERK5 Is a Critical Mediator of Inflammation-Driven Cancer","volume":"75","author":"Finegan","year":"2015","journal-title":"Cancer Res."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1158\/0008-5472.CAN-16-2565","article-title":"Increased T-cell Infiltration Elicited by Erk5 Deletion in a Pten-Deficient Mouse Model of Prostate Carcinogenesis","volume":"77","author":"Loveridge","year":"2017","journal-title":"Cancer Res."},{"key":"ref_89","first-page":"1","article-title":"An epithelial-to-mesenchymal transition-inducing potential of granulocyte macrophage colony-stimulating factor in colon cancer","volume":"7","author":"Chen","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"293","DOI":"10.18632\/oncotarget.22968","article-title":"Extracellular signal regulated kinase 5 and inflammasome in progression of mesothelioma","volume":"9","author":"Thompson","year":"2018","journal-title":"Oncotarget"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s13045-017-0528-6","article-title":"Role of AP-2\u03b1 and MAPK7 in the regulation of autocrine TGF-\u03b2\/miR-200b signals to maintain epithelial-mesenchymal transition in cholangiocarcinoma","volume":"10","author":"Zhang","year":"2017","journal-title":"J. Hematol. Oncol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/cas.12096","article-title":"Cancer-associated fibroblast and M2 macrophage markers together predict outcome in colorectal cancer patients","volume":"104","author":"Herrera","year":"2013","journal-title":"Cancer Sci."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1111\/cas.12745","article-title":"FGF-1\/-3\/FGFR4 signaling in cancer-associated fibroblasts promotes tumor progression in colon cancer through Erk and MMP-7","volume":"106","author":"Bai","year":"2015","journal-title":"Cancer Sci."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"152884","DOI":"10.1016\/j.prp.2020.152884","article-title":"Cancer-associated fibroblasts promote cell growth by activating ERK5\/PD-L1 signaling axis in colorectal cancer","volume":"216","author":"Zhang","year":"2020","journal-title":"Pathol. Res. Pract."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"4592","DOI":"10.1182\/blood-2009-04-217042","article-title":"A novel interplay between Epac\/Rap1 and mitogen-activated protein kinase kinase 5\/extracellular signal-regulated kinase 5 (MEK5\/ERK5) regulates thrombospondin to control angiogenesis","volume":"114","author":"Doebele","year":"2009","journal-title":"Blood"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"10227","DOI":"10.2147\/OTT.S226580","article-title":"Resveratrol Reverses Cigarette Smoke-Induced Urocystic Epithelial-Mesenchymal Transition via Suppression of STAT3 Phosphorylation in SV-HUC-1-Immortalized Human Urothelial Cells","volume":"12","author":"Sun","year":"2019","journal-title":"OncoTargets Ther."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"3893","DOI":"10.3892\/mmr.2017.6457","article-title":"ERK5 regulates tobacco smoke-induced urocystic epithelial-mesenchymal transition in BALB\/c mice","volume":"15","author":"Min","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.3892\/ijo.2017.3887","article-title":"Curcumin reverses benzidine-induced epithelial-mesenchymal transition via suppression of ERK5\/AP-1 in SV-40 immortalized human urothelial cells","volume":"50","author":"Liu","year":"2017","journal-title":"Int. J. Oncol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.3892\/or.2015.4130","article-title":"ERK5 positively regulates cigarette smoke-induced urocystic epithelial-mesenchymal transition in SV-40 immortalized human urothelial cells","volume":"34","author":"Geng","year":"2015","journal-title":"Oncol. Rep."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-020-15031-3","article-title":"Paradoxical activation of the protein kinase-transcription factor ERK5 by ERK5 kinase inhibitors","volume":"11","author":"Lochhead","year":"2020","journal-title":"Nat. Commun."}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/11\/2\/183\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:16:58Z","timestamp":1760159818000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/11\/2\/183"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,29]]},"references-count":100,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,2]]}},"alternative-id":["biom11020183"],"URL":"https:\/\/doi.org\/10.3390\/biom11020183","relation":{},"ISSN":["2218-273X"],"issn-type":[{"value":"2218-273X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,29]]}}}